Science Explorer Back to mapMap
Discussion
Company · Liège · Belgium

ImCyse (Belgium)

imcyse.com/enROR OpenAlex
Research works
5
▲ 60% vs 2018-21
Citations
35
6.6 per fractional work
Top-10% rate
32.1%
all institutions 10.0%
Open access
39%
world 40%
International
15%
world 18%
ImCyse (Belgium)

Not ranked overall: ImCyse (Belgium) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does ImCyse (Belgium) work in?

In all years, 45% of research at ImCyse (Belgium) is in Life Sciences, 27% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (27%), Medicine (27%), Business, Management and Accounting (19%). It does 1.4× the world's share of Life Sciences.

Life Sciences: 2 fractional works · 44.8% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 27.5% of its workMolecular Biology: 1 fractional works · 19.8% of its workGenetics: 0 fractional works · 7.7% of its workImmunology and Microbiology: 1 fractional works · 17.3% of its workImmunology: 1 fractional works · 17.3% of its workHealth Sciences: 1 fractional works · 26.9% of its workMedicine: 1 fractional works · 26.9% of its workHematology: 0 fractional works · 9.4% of its workOncology: 0 fractional works · 6.6% of its workSurgery: 0 fractional works · 3.6% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 3.2% of its workRheumatology: 0 fractional works · 1.9% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 1.5% of its workPathology and Forensic Medicine: 0 fractional works · 1.1% of its workSocial Sciences: 1 fractional works · 18.8% of its workBusiness, Management and Accounting: 1 fractional works · 18.8% of its workOrganizational Behavior and Human Resource Management: 1 fractional works · 18.8% of its workPhysical Sciences: 0 fractional works · 9.4% of its workComputer Science: 0 fractional works · 9.4% of its workArtificial Intelligence: 0 fractional works · 6.2% of its workComputer Vision and Pattern Recognition: 0 fractional works · 3.2% of its workALL ITS WORKImCyse (Belgium)5fractional works, all years
Life Sciences45%Physical Sciences9%Health Sciences27%Social Sciences19%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 5 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology127.5%
    2. Immunology and Microbiology117.3%
    1. Medicine126.9%
    1. Business, Management and Accounting118.8%
    1. Computer Science09.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from ImCyse (Belgium)?

The most cited paper from ImCyse (Belgium) is "First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes" (Jean Van Rampelbergh, Peter Achenbach, Richard David Leslie et al., 2023), with 28 citations. Next come "A future of AI-driven personalized care for people with multiple sclerosis" (24) and "Thioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse Model" (22).

Most cited papers
#PaperReleasedCitations
1 First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes Jean Van Rampelbergh, Peter Achenbach, Richard David Leslie et al. · BMC Medicine Open access 24 May 2023 28
2 A future of AI-driven personalized care for people with multiple sclerosis Jelle Praet, Lina Anderhalten, Giancarlo Comi et al. · Frontiers in Immunology Open access 19 Aug 2024 24
3 Thioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse Model Elin Malek Abrahimians, Luc Vander Elst, Vincent A. Carlier et al. · Frontiers in Immunology Open access 2 Mar 2016 22
4 First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes: an exploratory analysis of immune biomarkers Jean Van Rampelbergh, Peter Achenbach, Richard David Leslie et al. · BMC Medicine Open access 21 Jun 2024 17
5 T cell response to FVIII Marc G Jacquemin, Jean‐Marie Saint‐Remy · Cellular Immunology 26 Sep 2015 13
All 10 most cited papers, with filters and sorting

Which research topics does ImCyse (Belgium) publish most on?

By volume in 2022-now: Digital Media Forensic Detection, Anomaly Detection Techniques and Applications, Adversarial Robustness in Machine Learning and Diabetes and associated disorders.

Digital Media Forensic D…0Digital Media Forensic Detection: 0 fractional worksAnomaly Detection Techni…0Anomaly Detection Techniques and Applications: 0 fractional worksAdversarial Robustness i…0Adversarial Robustness in Machine Learning: 0 fractional worksDiabetes and associated …0Diabetes and associated disorders: 0 fractional worksDiabetes Management and …0Diabetes Management and Research: 0 fractional works
Computer Vision and Pattern RecognitionArtificial IntelligenceGeneticsEndocrinology, Diabetes and Metabolism

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Digital Media Forensic Detection Computer Vision and Pattern Recognition 0 works
  2. 2 Anomaly Detection Techniques and Applications Artificial Intelligence 0 works
  3. 3 Adversarial Robustness in Machine Learning Artificial Intelligence 0 works
  4. 4 Diabetes and associated disorders Genetics 0 works
  5. 5 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 0 works
  6. 6 vaccines and immunoinformatics approaches Molecular Biology 0 works
  7. 7 Pancreatic function and diabetes Surgery 0 works
  8. 8 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 0 works
  9. 9 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 0 works
  10. 10 Rheumatoid Arthritis Research and Therapies Rheumatology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available38.8%not open61.2%

World: 40% of research is openly available.

with international co-authors15.2%domestic only84.8%

World: 18% is written across borders.

How has ImCyse (Belgium)'s research output changed?

Output in 2022-2025 was 60% higher than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Liège

All research institutions in Liège

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about ImCyse (Belgium). Posts are plain text and can be reported.